This long-standing U.S. client has been working with us for many years, and we have developed a strong working relationship. While the previous order was still in the shipping process, the client placed a new order for peptide products based on their actual business needs, covering multiple categories such as tirzepatide, NAD+, retatrutide, MOTS-c, semax, and selank. Upon receiving the order, we promptly verified the current inventory levels for each product and communicated with the client to confirm the details. During our discussions, we noticed that the quantity selected by the client was just slightly below the threshold for free international shipping. Upon our proactive suggestion, the client gladly agreed to round up the total to 10 boxes, which not only saved on shipping costs but also improved shipping efficiency. We then carefully prepared, packaged, and reinforced the shipment to protect against shock, arranged for shipment via a reliable carrier, and promptly provided tracking information so the client could monitor the shipment's progress at any time. Recently, a post-sales follow-up confirmed that the shipment had been delivered to the customer in perfect condition. The customer expressed satisfaction with the entire process, and we are confident in our continued long-term partnership.
Business process
Semax and Selank are two artificially synthesized heptapeptide compounds. Both of them contain the stable sequence of proline-glycine-proline (PGP) in their structures. This design significantly enhances the enzymatic stability of the peptide chain in the body and prolongs the biological half-life. The two have different focuses in their functional applications, and each demonstrates unique research value in different fields.
Semax: Neuroprotection and Cognitive Function Regulation
The chemical sequence of Semax is Met-Glu-His-Phe-Pro-Gly-Pro. Its structure combines the 4-7 fragment of adrenocorticotropic hormone (ACTH) with the PGP tripeptide. This design enables it to exert neuroregulatory functions while avoiding the hormonal side effects of traditional glucocorticoids and having the ability to cross the blood-brain barrier.
In terms of neuroprotection, animal experiments have shown that Semax can promote the activation of cAMP response element binding protein, reduce the expression of matrix metalloproteinase-9 and pro-inflammatory cytokines (such as tumor necrosis factor-α and interleukin-1β), and simultaneously increase the level of anti-inflammatory factor interleukin-10. In the cerebral ischemia-reperfusion model, the infarct volume of rats treated with Semax was significantly reduced, and the neurological behavioral scores improved significantly. In addition, Semax was observed to be able to reduce the generation of reactive oxygen free radicals, protect neurons from oxidative stress damage, and show potential in promoting oligodendrocyte precursor cell differentiation and remyelination in traumatic brain injury models.
In the field of cognitive regulation, in the Alzheimer's disease transgenic mouse model, Semax can improve the spatial learning and memory abilities of the animals, while reducing the deposition of amyloid plaques and excessive phosphorylation of tau protein in the brain tissue.Behavioral experiments in healthy animals also show that Semax can enhance the long-term potentiation effect and optimize the synaptic transmission efficiency in the hippocampus.In the chronic stress model, Semax not only alleviates symptoms such as loss of pleasure and behavioral despair, but also protects memory function from being damaged by stress, suggesting that it is more applicable to cognitive decline associated with stress or aging.
In terms of clinical application, Semax has been used as a prescription drug in Russia and other countries for the treatment and rehabilitation of ischemic stroke.
Clinical data show that it can improve patients' neurological function scores and self-care ability. In terms of safety, the incidence of adverse reactions of Semax is relatively low, mostly manifested as mild pain at the injection site.
There is no liver or kidney function damage or cardiovascular events, and no reports of accumulation toxicity during long-term use.
Selank: Anti-anxiety and Immune Regulation
The chemical sequence of Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro. The first four amino acids are derived from the natural immune regulatory peptide tuftsin. By connecting with PGP, it retains its immune activity while significantly enhancing stability. Unlike Semax, Selank has a higher hydrophilicity. Its anti-anxiety effect may be achieved through the indirect transmission of peripheral immune signals to the central nervous system.
In the field of anxiety reduction research, Selank has demonstrated dose-dependent anti-anxiety effects in classic animal models such as the elevated cross maze and the light-dark box. The number of times the animals entered the open arm and the duration of their stay significantly increased. The mechanism may be related to the regulation of the GABAergic system and the endogenous neurosteroid metabolism.
At the same time, it can restore the negative feedback function of the hypothalamic-pituitary-adrenal axis and reduce the increase in cortisol levels caused by stress. Compared with benzodiazepine drugs, Selank does not show obvious side effects such as muscle relaxation, ataxia or amnesia while exerting its anti-anxiety effect.
In terms of immune regulation, Selank can enhance the phagocytic activity of macrophages, regulate the proportion of lymphocyte subgroups, and exhibit enhanced effects in cases of immune deficiency and inhibitory effects in cases of excessive inflammation. This demonstrates the characteristic of bidirectional balance regulation. In a mouse model of influenza A virus infection, prophylactic administration of Selank significantly reduced the viral load in the lungs, alleviated inflammatory pathological changes, and increased survival rates.
Mechanism studies revealed that it can induce the upregulation of interferon-α gene expression, without affecting the levels of cytokines such as interleukin-4, interleukin-10, and tumor necrosis factor-α, suggesting that its antiviral effect has certain selectivity. Additionally, Selank showed a protective effect on gastric mucosa in an acute gastric ulcer model induced by ethanol, with the lesion area being significantly smaller than that of the control group.
In terms of safety, toxicological studies have shown that Selank has extremely low acute toxicity and no abnormalities in organ function or tissue pathology were observed after long-term repeated administration. In clinical studies, mild drowsiness or dryness of the nasal cavity was occasionally observed, which was mild in degree and could resolve on its own. Overall, the tolerance was good.
Conclusion
Semax and Selank are two synthetic heptapeptides with related structures but distinct functions. They have accumulated extensive research bases in the fields of neuroprotection and cognitive regulation (Semax) and anti-anxiety and immune regulation (Selank). Both share the design strategy of the PGP stable sequence, embodying the classic idea of "functional fragment plus stable fragment" in peptide drug chemistry. However, most current studies are still concentrated on the preclinical stage or early clinical exploration. Many mechanism explanations still need further verification, and the exact effectiveness and long-term safety still require more solid support from large-sample randomized controlled trials. In the future, with the improvement of the research system, these two types of peptides are expected to play their respective roles in more precise application scenarios.
